PVH Corp.
PVH
$73.54
+2.57%
PVH Corp. designs and markets branded apparel globally, with its two powerhouse labels, Calvin Klein and Tommy Hilfiger, now generating virtually all revenue following the divestiture of smaller brands; the company operates roughly 1,400 standalone stores, about 1,500 shop-in-shops and concessions, e-commerce sites, and a wholesale network spanning department stores in more than 40 countries. As a mid-cap ($3.0 billion market cap) brand-licensing and wholesale platform in the Consumer Cyclical apparel manufacturing space, PVH is distinct for owning globally recognized designer trademarks while carrying meaningful retail and department-store channel exposure. The current investor narrative is dominated by a tug-of-war between deep-value appeal — a price-to-book near 0.62x and forward PE around 5.6x — and persistent execution anxiety, underscored by a June 2026 sell-off tied to a weak Q2 outlook and Middle East geopolitical risk to its crucial EMEA business, followed by a September 2026 earnings beat that nonetheless drew cautious "Hold" commentary. Analysts remain split, with recent downgrades (B of A to Underperform, Evercore ISI to In Line) offsetting Buy ratings from Goldman Sachs, UBS, BTIG, and Needham, leaving the stock in a show-me phase as investors weigh tariff and FX headwinds against brand strength and buyback-supported per-share economics.…
PVH
PVH Corp.
$73.54
Related headlines
Investment Opinion: Should I buy PVH Today?
The synthesized recommendation is a Hold with a speculative bias. The core thesis is that PVH is a deep-value play with a potential earnings recovery, but execution risks and negative momentum warrant caution. The analyst consensus is 'buy' with an average target of $90.83, implying 28.6% upside, but the recent downgrades and wide target range ($70-$128) suggest low conviction.
Supporting evidence includes the forward PE of 5.64x, which is a 50-70% discount to the sector, and a price-to-book of 0.62x, near historical lows. Gross margin of 57.52% is healthy, and free cash flow TTM of $550.5 million supports buybacks and dividends. However, revenue growth of 2.09% is weak, net margin is 0.28%, and ROE is 0.53%, indicating poor profitability. The implied upside to the average target is 28.6%, but the low target of $70 is at the current price, suggesting no margin of safety.
The biggest risks are a failure to meet the forward EPS estimate of $13.81, continued EMEA geopolitical tensions, and high volatility (beta 1.722). The rating would upgrade to Buy if the stock breaks above $80 and forward EPS estimates are maintained, or downgrade to Sell if revenue growth turns negative or gross margins fall below 55%. Relative to history and peers, PVH is undervalued on asset and sales multiples, but the discount is justified by low profitability; it is a value trap unless earnings recover.
Sign up to view all
PVH 12-Month Price Forecast
PVH presents a high-risk, high-reward scenario with a neutral stance due to conflicting signals. The deep value multiples and potential earnings recovery are attractive, but weak revenue growth, thin margins, and geopolitical risks are significant concerns. The analyst consensus is cautiously bullish, but recent downgrades and the stock's negative momentum suggest waiting for a better entry point. A successful execution of the earnings recovery could drive the stock to $100+, while a failure could see it retest $60. I would upgrade to bullish if the stock breaks above $80 with improving fundamentals, and downgrade to bearish if it breaks below $68 with estimate cuts.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on PVH Corp.'s 12-month outlook, with a consensus price target around $90.83 and implied upside of +23.5% versus the current price.
Average Target
$90.83
0 analysts
Implied Upside
+23.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$70 - $128
Analyst target range
PVH is covered by 12 analysts with a consensus recommendation of "buy" (recommendation mean of 2.31 on a scale where 1 is Strong Buy and 5 is Strong Sell), and the average target price of $90.83 implies approximately +28.6% upside from the current price of $70.64. The distribution leans bullish but with meaningful caution: recent actions include Buy ratings from Goldman Sachs, UBS, BTIG, and Needham (all maintained on 2026-06-05), while B of A Securities downgraded to Underperform from Neutral on 2026-06-25 and Evercore ISI cut to In Line from Outperform on 2026-06-04, and Wells Fargo and JP Morgan remain at Equal Weight and Neutral respectively. The consensus is therefore best characterized as cautiously bullish — the average target is well above the current price, but the downgrade trend and the presence of an Underperform rating suggest conviction is eroding, and the September 2026 earnings beat (which drew a "Hold" rating from Zacks) has not yet translated into broad-based target increases.
The target range is wide, from a low of $70.00 to a high of $128.00, a spread of $58.00 or roughly 83% of the low target, which signals high uncertainty and low analyst conviction about the earnings recovery trajectory. The low target of $70.00 is essentially at the current price, implying that the most bearish analyst sees no upside and expects the company's challenges — EMEA geopolitical risk, tariff pressures, and margin compression — to persist; notably, this low target is below the consensus forward EPS estimate of $13.81 would suggest at even a 6x multiple, indicating the bear case is built on estimate cuts rather than multiple compression alone. The high target of $128.00 implies roughly +81% upside and would require both multiple expansion (to roughly 9-10x forward earnings) and successful execution on the earnings recovery, likely driven by gross margin expansion, SG&A leverage, and a resolution of Middle East tensions that would restore EMEA revenue growth. The wide spread, combined with the recent downgrade activity and the stock's 1.72 beta, means investors should expect continued volatility and should treat the consensus target as a directional signal rather than a precise price objective.
Bulls vs Bears: PVH Investment Factors
The bear case currently has stronger evidence due to recent negative momentum, weak revenue growth, and analyst downgrades, but the bull case is supported by deep value multiples and a potential earnings recovery. The most important tension is whether the forward EPS estimate of $13.81 is achievable; if it is, the stock is dramatically undervalued, but if estimates are cut, the low forward PE is a value trap. The market is pricing in a permanent impairment of brand equity, but the strong gross margin suggests the issue is operational and fixable. The wide analyst target range of $70 to $128 reflects high uncertainty, and the stock's high beta means it will remain volatile. A resolution of EMEA geopolitical risks and successful margin recovery are key to unlocking value.
Bullish
- Deep value multiples: PVH trades at a forward PE of 5.64x and a price-to-book of 0.62x, representing a 50-70% discount to the apparel sector's typical 12-20x PE range. The price-to-sales ratio of 0.33x is the lowest in the company's historical dataset, suggesting extreme pessimism is already priced in.
- Strong gross margins: Gross margin stands at 57.52% trailing and 58.57% in the latest quarter, well above many apparel peers. This indicates the earnings weakness is driven by operating expenses and one-time charges, not a structural erosion of brand pricing power.
- Analyst upside potential: The consensus analyst target price of $90.83 implies 28.6% upside from the current $70.64, with a high target of $128.00 suggesting 81% upside. The consensus recommendation is 'buy' with a mean of 2.31, indicating analysts still see value despite recent downgrades.
- Earnings recovery expected: Forward EPS is estimated at $13.81 versus trailing EPS of $0.0085, implying a massive 21x earnings normalization. This recovery is supported by Q1 2026 net income of $88 million, a sharp turnaround from the Q1 2025 net loss of $44.8 million.
Bearish
- Weak revenue growth: Revenue grew only 2.09% year-over-year in the latest quarter to $2.025 billion, and consensus forward revenue of $9.474 billion implies flat-to-low-single-digit growth. This is well below what a brand portfolio of Calvin Klein and Tommy Hilfiger's caliber should command.
- Thin and volatile profitability: Trailing net margin is just 0.28% and ROE is 0.53%, well below cost of capital. The company swung from a Q4 2026 net loss of $158.3 million to Q1 2026 net income of $88 million, illustrating extreme earnings volatility.
- High debt and leverage: Debt-to-equity stands at 0.897, and interest coverage of 7.5x provides only moderate cushion. With $1.068 billion in quarterly SG&A against $1.186 billion in gross profit, fixed cost deleverage is a persistent risk.
- Geopolitical and tariff headwinds: The June 2026 sell-off was driven by a weak Q2 outlook and Middle East geopolitical risk to the crucial EMEA business. Tariff pressures and FX headwinds continue to threaten margins and revenue growth.
PVH Technical Analysis
PVH is in a choppy, range-bound consolidation with a distinctly negative longer-term tilt: the 1-year price change is -13.87% and the 3-month change is -13.81%, leaving the current price of $70.64 in the middle-lower portion of its 52-week range of $59.60 to $100.75 — roughly 26.6% above the 52-week low and about 29.9% below the 52-week high, or approximately 26.6% of the way up the range. That positioning signals neither a clean momentum breakout nor a capitulation low, but rather a market that has repeatedly rejected the $95-$100 zone (April and May 2026 highs of $98.81 and $98.00) while building a base above $70. The 6-month change of +16.05% versus the 1-year change of -13.87% confirms the stock has recovered off its lows but has given back a substantial portion of that spring rally.
Short-term momentum has turned decisively negative and is diverging from the still-positive 6-month trend: the 1-month change is -13.42% and the 3-month change is -13.81%, meaning the stock has surrendered essentially all of its 3-month gains in just the past month, with the decline from the August 3 high of $88.80 to the September 9 low of $68.51 representing a roughly 22.8% drawdown in about five weeks. This acceleration of selling pressure — the September 9 close of $68.51 was the lowest print since March 2026 — suggests the pullback is more than routine mean reversion and reflects genuine fundamental repricing after the June guidance cut. Relative strength confirms the underperformance: PVH's 1-month relative strength versus SPY is -12.36 percentage points and its 1-year relative strength is -30.09 points, though the 6-month relative strength of +0.65 points shows PVH briefly kept pace with the market during the spring rebound. The modest September 11 bounce (+1.86% on the day to $70.64) on light volume of 873,237 shares offers only tentative evidence of stabilization.
Key technical levels are well defined: support sits at the 52-week low of $59.60, with the $68-$70 zone (the September 2026 lows) acting as the first line of defense, while resistance is anchored at the 52-week high of $100.75, with intermediate supply around $88-$98 where the stock failed twice in 2026. A decisive breakdown below $68 would open the door to a retest of the $59.60 low and likely trigger momentum-driven selling, whereas reclaiming $80 would signal the correction has run its course and put the $88-$98 band back in play. Volatility is a critical consideration: the beta of 1.722 means PVH is roughly 72% more volatile than the S&P 500, and the maximum drawdown of -32.0% over the observed period underscores that position sizing must be conservative — a 1.7 beta stock can move 1.7% for every 1% move in the market, amplifying both the risk of the current downtrend and the potential reward of any reversal.
Beta
1.72
1.72x market volatility
Max Drawdown
-32.0%
Largest decline past year
52-Week Range
$60-$101
Price range past year
Annual Return
-12.5%
Cumulative gain past year
| Period | PVH Return | S&P 500 |
|---|---|---|
| 1m | -6.6% | -0.6% |
| 3m | -4.6% | +2.1% |
| 6m | +16.2% | +17.6% |
| 1y | -12.5% | +15.7% |
| ytd | +8.4% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PVH Fundamental Analysis
PVH's revenue trajectory is modestly positive but decelerating: the most recent quarter (ending 2026-05-03) delivered revenue of $2.025 billion, up 2.09% year-over-year, following $2.505 billion in Q4 2026 (down from $2.372 billion in Q4 2025), $2.294 billion in Q3 2025, and $2.167 billion in Q2 2025. The year-over-year comparison is flattered by an easy prior-year base — Q1 2025 revenue was $1.984 billion — and the sequential decline from Q4 to Q1 reflects normal seasonal patterns, but the low-single-digit growth rate is well below what a brand portfolio of Calvin Klein and Tommy Hilfiger's caliber should command. Segment data shows product revenue of $2.257 billion dwarfing royalty revenue of $94.4 million, meaning the business remains heavily dependent on owned wholesale and retail channels rather than the higher-margin licensing model, which limits operating leverage and exposes results to department-store traffic trends and EMEA geopolitical risk. The consensus revenue estimate of $9.474 billion for the forward period implies roughly flat-to-low-single-digit growth, confirming that the investment case rests on margin recovery and capital returns rather than top-line acceleration.
Profitability is thin and volatile at the net level despite healthy gross margins: Q1 2026 net income was $88 million on a 4.35% net margin, a sharp improvement from the Q4 2026 net loss of $158.3 million (-6.32% margin) and the Q1 2025 net loss of $44.8 million (-2.26% margin), but the trailing net margin of just 0.28% and trailing EPS of $0.0085 illustrate how fragile the bottom line has been. Gross margin remains the company's anchor at 57.52% (trailing) and 58.57% in the latest quarter, consistent with the 56.0%-59.8% band over the past eight quarters, which is respectable for apparel manufacturing and reflects brand pricing power. However, the operating margin of 7.34% and the gap between gross and operating profitability — driven by $1.068 billion in quarterly SG&A against $1.186 billion in gross profit — shows that fixed cost deleverage is the core earnings problem; the Q4 2026 effective tax rate of 169% (a $387.7 million tax expense on $229.4 million pretax income) and the Q1 2025 tax benefit distortion further muddy the earnings picture. The forward EPS estimate of $13.81 versus trailing EPS of $0.0085 implies the market expects a dramatic profitability normalization, which is either a massive opportunity if achieved or a significant risk if macro conditions deteriorate.
Balance sheet and cash flow metrics paint a mixed but manageable picture: debt-to-equity stands at 0.897, the current ratio is a healthy 1.517, and interest coverage of 7.5x (Q1 2026) provides adequate cushion, while the cash balance of $592.5 million at quarter-end covers near-term obligations. Free cash flow is the swing factor — TTM FCF is $550.5 million, but quarterly FCF has been highly seasonal and volatile, ranging from -$98.1 million in Q1 2025 to +$539.7 million in Q4 2026, with Q1 2026 at -$86 million due to a $185.5 million working capital outflow. ROE of just 0.53% and ROA of 3.70% are well below cost of capital, indicating the company is not currently earning adequate returns on its asset base, though the Q4 2026 ROE of -3.30% shows how quickly these metrics swing with quarterly earnings. The dividend yield of 0.25% with a payout ratio of 29.6% is modest and sustainable, and the company has been an active buyer of its own stock ($572.2 million repurchased in Q1 2025, $244.6 million in Q4 2025), which supports per-share metrics but consumes cash that could otherwise deleverage the balance sheet.
Quarterly Revenue
$2.0B
2026-05
Revenue YoY Growth
+2.1%
YoY Comparison
Gross Margin
58.6%
Latest Quarter
Free Cash Flow
$550500000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PVH Overvalued?
Because PVH's trailing net income is positive but negligible (trailing EPS of $0.0085, net margin 0.28%), the trailing PE of 118.5x is economically meaningless and distorted by a near-zero earnings base; the more informative metric is the forward PE of 5.64x, which reflects the consensus forward EPS estimate of $13.81 and signals that the market expects a dramatic earnings recovery. The enormous gap between the trailing PE (118.5x) and forward PE (5.64x) implies the market is pricing in a roughly 21x increase in earnings, a level of expected normalization that is either a compelling value setup or a warning that estimates may be too optimistic. Supporting the value case, the price-to-sales ratio of 0.33x, price-to-book of 0.62x, and EV/Sales of 0.717x are all deeply depressed, while EV/EBITDA of 12.68x is more moderate and suggests the enterprise value is not as cheap as the equity multiples imply.
Relative to typical apparel and consumer cyclical sector averages — where PE ratios generally range from 12x to 20x and PS ratios from 0.8x to 1.5x — PVH's forward PE of 5.64x represents a roughly 50-70% discount to sector norms, and its PS of 0.33x is roughly 60-75% below the sector's typical range. This discount is partly justified: net margin of 0.28% and ROE of 0.53% are far below what a healthy branded apparel company should earn, and the 2.09% revenue growth rate is uninspiring. However, the gross margin of 57.52% is actually above many apparel peers, suggesting the earnings weakness is an operating-expense and one-time-charge problem rather than a structural brand-value problem, which is why some analysts (Goldman Sachs, UBS, BTIG, Needham) maintain Buy ratings despite the depressed multiples. The PB ratio of 0.62x is particularly striking — the market values PVH's equity at a 38% discount to book value, implying either that book value is overstated (goodwill impairment risk) or that the market is excessively pessimistic about the brand portfolio's earning power.
Historically, PVH's valuation has compressed dramatically: the PE ratio ranged from 4.2x to 14.7x in 2021-2022, the PS ratio was 2.3x-3.4x in 2021-2022 versus 0.33x today, and the PB ratio was 1.25x-1.56x in 2021 versus 0.62x now. The current PS of 0.33x is the lowest in the entire historical dataset, and the PB of 0.62x is near the bottom of its multi-year range (the only comparable reading was 0.62x in Q4 2026). This extreme historical compression suggests the market is pricing in either a permanent impairment of PVH's brand equity or a cyclical trough in earnings — if it is the latter, the stock is near a generational value opportunity; if the former, the cheap multiples are a value trap. The dividend yield of 0.25% is also near historical lows, and the PEG ratio of -1.25 (negative due to negative earnings growth) provides no useful signal, reinforcing that this is a special-situation, earnings-recovery story rather than a growth-at-a-reasonable-price investment.
PE
118.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~15x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.7x
Enterprise Value Multiple
Investment Risk Disclosure
PVH faces significant financial and operational risks. The company's net margin is razor-thin at 0.28%, with trailing EPS of just $0.0085, and ROE of 0.53% is well below the cost of capital. Debt-to-equity of 0.897 and interest coverage of 7.5x provide only moderate cushion, while free cash flow is highly seasonal, ranging from -$98.1 million in Q1 2025 to +$539.7 million in Q4 2026. Revenue growth of 2.09% is anemic, and the business is heavily dependent on wholesale and retail channels, exposing it to department store traffic declines and EMEA geopolitical risk.
Market and competitive risks are elevated. The stock trades at a forward PE of 5.64x, but this is only cheap if earnings recover; if estimates are cut, the multiple could compress further. The beta of 1.722 means PVH is 72% more volatile than the S&P 500, amplifying market downturns. Recent downgrades from B of A (Underperform) and Evercore ISI (In Line) reflect eroding confidence, and the wide analyst target range of $70 to $128 signals low conviction. Tariff and FX headwinds, particularly in EMEA, pose ongoing threats to margins and revenue.
The worst-case scenario involves a failure to achieve the consensus EPS estimate of $13.81, leading to a retest of the 52-week low of $59.60, which would represent a 15.6% decline from the current price of $70.64. If EMEA geopolitical tensions escalate and consumer spending weakens, revenue could decline, pushing the stock below $60. The maximum drawdown over the observed period was -32.0%, and with a beta of 1.722, a market correction could easily trigger a 30%+ decline. Investors could lose 15-30% from current levels in a bear case.
FAQ
The key risks are: 1) Financial risk: net margin of 0.28% and ROE of 0.53% indicate poor profitability, with debt-to-equity at 0.897. 2) Competitive/market risk: revenue growth of 2.09% is weak, and the stock has a beta of 1.722, making it highly volatile. 3) Geopolitical risk: EMEA exposure is threatened by Middle East tensions, which caused a 22.8% drawdown in five weeks. 4) Execution risk: failure to achieve the $13.81 EPS estimate could lead to a retest of the 52-week low of $59.60. The most severe risk is a combination of estimate cuts and geopolitical escalation, which could cause a 30%+ decline.
The 12-month forecast has three scenarios: bull case (25% probability) targets $100-$128, assuming successful earnings recovery and multiple expansion; base case (50% probability) targets $80-$95, assuming gradual recovery in line with consensus; bear case (25% probability) targets $59.60-$70, assuming estimate cuts and geopolitical escalation. The base case is most likely, with the stock trading around the analyst average target of $90.83. The key assumption is that forward EPS of $13.81 is achieved; if not, the bear case prevails.
PVH appears undervalued on most metrics. The forward PE of 5.64x is a 50-70% discount to the apparel sector's typical 12-20x range, and the price-to-sales of 0.33x is the lowest in its historical dataset. The price-to-book of 0.62x means the market values equity at a 38% discount to book value. However, the trailing PE of 118.5x is distorted by near-zero earnings. The market is pricing in a permanent impairment of brand equity, but if earnings normalize, the stock is deeply undervalued. The discount is partly justified by low profitability, so it could be a value trap if estimates are cut.
PVH is a speculative buy for value investors willing to accept high risk. The stock trades at a forward PE of 5.64x and a price-to-book of 0.62x, with analyst targets implying 28.6% upside to $90.83. However, revenue growth is only 2.09%, net margin is 0.28%, and the stock has a beta of 1.722, making it volatile. The biggest downside risk is a retest of the 52-week low of $59.60, representing a 15.6% decline. It is a good buy only if you believe the earnings recovery to $13.81 EPS is achievable and can tolerate short-term volatility.
PVH is more suitable for long-term value investors than short-term traders. The stock is in a turnaround phase with high volatility (beta 1.722) and negative momentum, making short-term trading risky. The dividend yield is only 0.25%, so income is not a reason to hold. However, the deep value multiples and potential earnings recovery could reward patient investors over a 2-3 year horizon. A minimum holding period of 18-24 months is suggested to allow the earnings recovery to materialize. Short-term traders could play the range between $68 and $88, but with high risk.